| | JULY 20234The pharmaceutical industry has been under immense pressure ever since the first case of COVID-19 was reported. However, one of the silver linings of the pandemic was that it triggered more remarkable ways to research and develop vaccines. Eventually, the pharmaceutical industry came out all guns blazing, developing COVID-19 vaccines in record time. In the process, the pandemic forced the implementation of many technologies and innovations, which were just a part of the conversation otherwise. COVID-19 made the BioTech industry think about the similar healthcare catastrophes ahead of us and how to be prepared to face such predicaments, hence the increasing focus on approaches like Immunomodulatory therapy.It's no secret that pharmaceutical and life sciences companies can seize this moment to transform their businesses. However, the investors will continue to demand both growth and profitability at the same time. Hence, CFOs must find ways to ensure shorter timelines and intact quality with lower costs. That means coordinating with other C-suite executives, reimagining work, and tech-enabling the organization. They need to build business strategies that deliver sustainable outcomes that are quickly reflected in profit and loss (P&L) statements.This also means this is the year to monetize investments in digital technology. Indeed, many of these technologies, some of them in early development, are already creating significant impacts. According to a report by PwC, a neuroscience business recently saved nearly 40 percent on a pivotal Phase III study. It reduced the timeline by 25 percent by harnessing the power of intelligent clinical trial design. For a larger concern with a portfolio of Phase III assets, this can be equated to hundreds of millions of dollars in potential savings and countless benefits for patients awaiting new treatment options. The mantra for the pharma CFOs is taking that leap of faith.Sujith VasudevanManaging Editoreditor@ceoinsightsindia.comBuilding a Sustainable Strategy Editorial Vol 04 · Issue 5 - 1 · JULY, 2023 Publisher Alok Chaturvedi Managing Editor Sujith Vasudevan Senior Designer Girisha M Visualizers Asokan S. V. Vayshnavi P. D. NoidaRohit Raghubanshi Garima Anandadvertise@ceoinsightsindia.comEditorial queries editor@ceoinsightsindia.comAdvertising ManagersAbhay Katiyar To subscribeVisit https://www.ceoinsightsindia.com/subscribe/ or send emailto subscription@ceoinsightsindia.comMagazine Price is Rs. 150 per issuePublisher Alok ChaturvediPrinted and Published By Alok Chaturvedi on behalf of Info Connect Web Technolo-gies India Pvt. Ltd., and Printed at Precision Fototype Services at Sri Sabari Shopping Complex, 24 Residency Road Bangalore-560025 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Copyright © 2023 Info Connect Web Technologies India Pvt. Ltd., All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.VP - Sales & Marketing Amrit SinghCirculation Manager Magendran Perumal Editorial Hima P. M. Nalini Brahmanapalli Roopalatha H P Tejaswini
< Page 3 | Page 5 >